Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

AKT Inhibitor in Oestrogen Positive Breast Cancer (STAKT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02077569
Recruitment Status : Completed
First Posted : March 4, 2014
Last Update Posted : May 4, 2017
Sponsor:
Collaborators:
AstraZeneca
Cancer Research UK
National Cancer Research Network
Information provided by (Responsible Party):
University of Nottingham

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 21, 2017
Actual Study Completion Date : February 21, 2017